Pedersen Michael Lynge
Greenland Center of Health Research, Institute of Nursing and Health Science, University of Greenland, Nuuk, Greenland.
Queen Ingrid Primary Health Care Center, Box 3333, 3900 Nuuk, Greenland.
Diabetol Metab Syndr. 2017 May 3;9:30. doi: 10.1186/s13098-017-0230-4. eCollection 2017.
Sixty years ago diabetes was almost non-existent in Greenland and until the beginning of this century awareness of diabetes was quite minimal. A high prevalence of undiagnosed diabetes has been reported in repeated population surveys. Increased focus on diabetes has been made a priority within the health care system since 2008, and in 2010 glycated haemoglobin was introduced as a diagnostic tool to further facilitate the diagnosis of diabetes.
The aim of this study was to estimate the age and gender specific use of glycated haemoglobin in 2014 and 2015, as an indicator of diagnostic activity and awareness of diabetes, and to estimate the prevalence of diagnosed pre-diabetes and diabetes among adults in Greenland aged 20-79 years of age.
The study was performed as an observational, cross sectional register study based on information gleaned from the electronically laboratory system used in Greenland including all patients tested with glycated haemoglobin at least once in 2014 or 2015.
A total of 10,127 patients were tested with glycated haemoglobin in 2014 or 2015 corresponding to 18.1% of the whole population. Among adults aged 20-79 years 9506 patients were tested corresponding to 24.0% of the total adult population. More females (32.5%) than males (16.5%) aged 20-79 years old were tested (p < 0.001). The prevalence of diagnosed diabetes and high risk pre-diabetes among adults aged 20-79 years was 4.3 and 6.8% respectively.
In conclusion use of glycated haemoglobin is widely used in the health care system in Greenland indicating a high awareness of diabetes in the population and by the health care system. Still, awareness of undiagnosed diabetes remains an important issue and additional strategies targeting males under 70 years old must be considered.
六十年前，糖尿病在格陵兰几乎不存在，直到本世纪初，对糖尿病的认知都非常有限。在多次人群调查中均报告了未诊断糖尿病的高患病率。自2008年以来，医疗保健系统已将对糖尿病的更多关注作为优先事项，并且在2010年引入糖化血红蛋白作为诊断工具以进一步促进糖尿病的诊断。
本研究的目的是估计2014年和2015年糖化血红蛋白按年龄和性别的使用情况，作为糖尿病诊断活动和认知的指标，并估计格陵兰20至79岁成年人中已诊断的糖尿病前期和糖尿病的患病率。
该研究作为一项观察性横断面登记研究进行，基于从格陵兰使用的电子实验室系统收集的信息，包括2014年或2015年至少接受过一次糖化血红蛋白检测的所有患者。
2014年或2015年共有10127名患者接受了糖化血红蛋白检测，占总人口的18.1%。在20至79岁的成年人中，有9506名患者接受了检测，占成年总人口的24.0%。20至79岁接受检测的女性（32.5%）多于男性（16.5%）（p < 0.001）。20至79岁成年人中已诊断糖尿病和高风险糖尿病前期的患病率分别为4.3%和6.8%。
总之，糖化血红蛋白在格陵兰的医疗保健系统中被广泛使用，这表明民众和医疗保健系统对糖尿病的认知度很高。尽管如此，未诊断糖尿病的认知仍然是一个重要问题，必须考虑针对70岁以下男性的额外策略。
